You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human epidermal growth factor receptor 2 Positive Breast Cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Among Hormone Receptor-positive/Human Epidermal Growth Factor

Recruiting
  • Breast Cancer
    • Tokyo, Japan
      Pfizer Japan Inc.
    Nov 29, 2021

    Early-stage Breast Cancer, HER2-positive Breast Cancer Trial in Sweden (Docetaxel, Carboplatin, Trastuzumab)

    Terminated
    • Early-stage Breast Cancer
    • HER2-positive Breast Cancer
    • Göteborg, Sweden
    • +7 more
    Sep 22, 2021

    Prostate Cancer Metastatic, Advanced Breast Cancer, Castration-resistant Prostate Cancer Trial in Denmark, Finland, France

    Active, not recruiting
    • Prostate Cancer Metastatic
    • +3 more
    • Copenhagen, Denmark
    • +3 more
    Mar 23, 2022

    Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCE®))

    Recruiting
    • Breast Cancer
    • ARV-471
    • ARV-471 in combination with palbociclib (IBRANCE®)
    • Palo Alto, California
    • +16 more
    Jan 30, 2023

    HER2-positive Breast Cancer Trial in Birmingham ([18F]-FDG)

    Recruiting
    • HER2-positive Breast Cancer
    • Birmingham, Alabama
      The University of Alabama at Birmingham
    Jan 31, 2022

    HR-positive, HER2-negative Breast Tumors Trial in China (TQB3616 capsule, Placebo, Fulvestrant injection)

    Not yet recruiting
    • HR-positive, HER2-negative Breast Neoplasms
    • TQB3616 capsule
    • +2 more
    • Bengbu, Anhui, China
    • +5 more
    May 6, 2022

    Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)

    Active, not recruiting
    • Breast Cancer
    • San Francisco, California
    • +17 more
    Jan 30, 2023

    Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer Trial in Boston (Breast Cancer Treatment

    Completed
    • Breast Cancer
    • +3 more
    • Breast Cancer Treatment Decision Aid for women 70+
    • Usual Care
    • Boston, Massachusetts
    • +1 more
    Mar 10, 2022

    Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • +2 more
    • trastuzumab(Henlius®) combined with Pertuzumab(Perjeta®) and Chemotherapy
    • Beijing, Beijing, China
      Ruyan Zhang
    Dec 27, 2021

    Breast Tumors, Tumor Metastasis Trial in India (Abemaciclib, Nonsteroidal Aromatase Inhibitor (NSAI), Fulvestrant)

    Recruiting
    • Breast Neoplasms
    • Neoplasm Metastasis
    • Hyderabad, Andhra Pradesh, India
    • +15 more
    Aug 8, 2022

    Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center
    Jan 17, 2022

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Orange City, Florida
    • +27 more
    Jul 19, 2023

    Breast Cancer Trial in Shenyang (Palbociclib + Letrozole, Letrozole)

    Recruiting
    • Breast Cancer
    • Shenyang, Liaoning, China
    • +2 more
    Jul 18, 2021

    Metastatic Breast Cancer Trial in Japan, United States (Patritumab Deruxtecan)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Patritumab Deruxtecan
    • Newnan, Georgia
    • +25 more
    Dec 5, 2022

    Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer Trial in United States (NUV-422, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • +7 more
    • Anaheim, California
    • +4 more
    Apr 6, 2022

    Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

    Completed
    Has Results
    • Estrogen Receptor Positive Breast Cancer
    • Houston, Texas
    • +2 more
    Aug 27, 2021

    Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

    Active, not recruiting
    • Breast Neoplasms
    • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
    • +7 more
    • Birmingham, Alabama
    • +26 more
    Dec 21, 2022

    HR+/HER2- Advanced and/or Metastatic Breast Cancer Trial (HS-10342)

    Not yet recruiting
    • HR+/HER2- Advanced and/or Metastatic Breast Cancer
    • (no location specified)
    Sep 7, 2021

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer Trial in Philadelphia (Palbociclib, Olaparib,

    Recruiting
    • Metastatic Breast Cancer
    • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 20, 2021

    Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor Trial in Indianapolis, Winston-Salem

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Indianapolis, Indiana
    • +1 more
    Sep 28, 2021

    Breast Cancer Trial in Spain (Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • Barcelona, Spain
    • +7 more
    Sep 3, 2021

    Breast Cancer Trial in China (Docetaxel, Pertuzumab, Placebo)

    Completed
    Has Results
    • Breast Cancer
    • Beijing, China
    • +14 more
    Nov 15, 2021

    Breast Cancer Trial in Shanghai (Pyrotinib, Placebo)

    Active, not recruiting
    • Breast Cancer
    • Shanghai, China
      Fudan University Cancer Hospital
    May 20, 2021

    Primary Breast Cancer Trial (SPECT)

    Not yet recruiting
    • Primary Breast Cancer
    • (no location specified)
    Jun 19, 2023

    Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

    Enrolling by invitation
    • Breast Cancer Female
    • Tomsk, Russian Federation
      Olga
    Jun 19, 2023